Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis
Year: 2010
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Authors: W. Kruis, L. Jonaitis, J. Pokrotnieks, T. L. Mikhailova, M. Horynski, M. Bátovský, Y. S. Lozynsky, Y. Zakharash, I. Rácz, K. Kull, A. Vcev, M. Faszczyk, K. Dilger, R. Greinwald, R. Mueller, the International Salofalk OD Study Group
Institutions: University of Cologne, Evangelisches Krankenhaus Kalk, Lithuanian University of Health Sciences, Pauls Stradiņš Clinical University Hospital, State Scientific Center of Coloproctology, University Hospital Bratislava, Danylo Halytsky Lviv National Medical University, Lviv Medical University, Bogomolets National Medical University, Petz Aladár Megyei Oktató Kórház, Tartu University Hospital, University of Osijek, Barzilai Medical Center, Dr Falk Pharma (Germany)
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Dr. Falk Pharma
OpenAlex ID: W1506122018